SIS
KYNB

Sound Income Strategies’s Kyntra Bio KYNB Stock Holding History

Sound Income Strategies’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4
Closed -$6K – 745
2018
Q2 		$6K Hold
4
– – ﹤0.01% 391
2018
Q1 		$5K Buy
+4
New +$5.27K ﹤0.01% 387

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sound Income Strategies's KYNB Position: Q3 2018 in Review

Sound Income Strategies sold out of Kyntra Bio (KYNB) in Q3 2018, closing a stake of 4 shares — an estimated $6K sold.

Sound Income Strategies first reported a position in KYNB in Q1 2018 and held it in 2 quarters. The position peaked at $6K in Q2 2018. 187 funds tracked by Wall St. Rank hold KYNB as of Q3 2018.

  • Sound Income Strategies reported no remaining Kyntra Bio position as of Q3 2018 after selling out during the quarter.
  • Sound Income Strategies sold 4 Kyntra Bio shares in Q3 2018, an estimated $6K.
  • Sound Income Strategies first reported a position in Kyntra Bio in Q1 2018 and held it in 2 quarters.
  • Sound Income Strategies's Kyntra Bio position peaked at $6K in Q2 2018.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2018.

Based on Sound Income Strategies's 13F filing for Q3 2018, filed 1 Oct 2018.